NCT00022256: Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
|
| Completed | 2 | | US | motexafin gadolinium, radiation therapy | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | 04/03 | 04/03 | | |
NCT00387790: Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma |
|
|
| Completed | 2 | 64 | US | motexafin gadolinium, gadolinium texaphyrin, Gd (III) Texaphryin, Gd-Tex, PCI-0120, Xcytrin, 3-dimensional conformal radiation therapy, 3D conformal radiation therapy, 3D-CRT | National Cancer Institute (NCI) | Untreated Childhood Brain Stem Glioma | 04/10 | 04/10 | | |
RTOG 0513, NCT00305864: Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
|
| Completed | 1/2 | 118 | US | 3-Dimensional Conformal Radiation Therapy, 3-dimensional radiation therapy, 3D CONFORMAL RADIATION THERAPY, 3D CRT, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Motexafin Gadolinium, API-GP3, gadolinium texaphyrin, Gd (III) Texaphryin, Gd-Tex, PCI-0120, Xcytrin, Temozolomide, CCRG-81045, Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-, M & B 39831, M and B 39831, Methazolastone, RP-46161, SCH 52365, Temcad, Temodal, Temodar, Temomedac | National Cancer Institute (NCI), Radiation Therapy Oncology Group | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma | 02/11 | 03/11 | | |
